Fidelity SPDR Advertisement
Home > Boards > Free Zone > All Trading - Technical > GoodFellas Big Board Catalyst and Chart Plays

GNOM - Research/DD summary & charts !

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
dDT  Member Profile
Member Level 
Followed By 477
Posts 67,688
Boards Moderated 2
Alias Born 03/31/08
160x600 placeholder
Guard Shot Near Canada Parliament
Canada's parliament building and other government offices are locked down in Ottawa after an armed attack left at least one injured guard at the country's main war memorial.
More Top Equities Stories Of The Day
Hong Kong Protests Expose Differences in Local Media
FTSE 100 Climbs As Oil Stocks Advance
Safran Revenue Rises on Sustained Demand for Jet Engines
Correction to AT&T Earnings Preview Story
Stifel Financial to Hire Two Former Merrill Lynch Advisers
Five HP Executives Sell $12.3 Million in Stock -- Barron's
U.S. Stocks Gain, but IBM Weighs on Dow
U.S. Stock Futures Hover Near Even
dDT Member Level  Saturday, 01/07/12 08:05:22 AM
Re: dDT post# 1694
Post # of 81332 
GNOM - Research/DD summary & charts !

Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. Its Complete Genomics Analysis platform combines its proprietary human genome sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research. The company's human genome sequencing services have applications in cancer research, Mendelian disease research, rare variant disease research, and clinical trial optimization. Its customers include academic and government research centers, and biopharmaceutical companies. The company was founded in 2005 and is headquartered in Mountain View, California.

Company's website: http://www.completegenomics.com/

Financial Reports: http://ir.completegenomics.com/financials.cfm

SEC filings: http://ir.completegenomics.com/sec.cfm

Nasdaq.com Stock Research - Analyst Summary

http://www.nasdaq.com/symbol/gnom/analyst-research


Contacts

Investor Relations Contact:
Scott Sandler
Director, Financial Planning & Analysis
Complete Genomics, Inc.
ssandler@completegenomics.com
650.943.2788

GNOM Chart


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist